GLPwatch
Trials (2139)
Page 23 of 36.
- A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
- Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
- NC Works4Health: Reducing Chronic Disease Risks in Socioeconomically Disadvantaged, Unemployed Populations
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
- A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
- Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
- A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
- Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
- Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
- A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea
- Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
- A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
- Prediction of the SEPRA Diabetes Trial in Healthcare Claims Data
- Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
- Comparing Facial Aging Between Identical Twins With 3D Imaging
- Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
- Effect of Renal Impairment on the Pharmacokinetics of NN9535
- Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
- A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
- Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
- A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants
- The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
- A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
- First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes
- Effect of GLP-1 on Angiogenesis
- Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)
- A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
- Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure
- Closed Loop System With Pramlintide Versus Exenatide
- Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
- A Study of a Weight Loss Intervention in People With Endometrial Cancer
- Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
- Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
- GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
- Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
- Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
- The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
- Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
- A Study of LY3025876 in Participants With Diabetes
- Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
- Genetic, Microbiological and Behavioral Factors in Obesity
- Semaglutide's Weight Loss Effects in Obesity
- STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
- Effects of Glucagon Like Peptide-1 on No-reflow
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
- RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.
- The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
- A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
- Obesity Treatment to Improve Diabetes
- A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
- LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes